Jignesh Patel

Papers

1

Total Citations

12

H-Index

1

About

Jignesh Patel is a leading clinical researcher in ophthalmology, whose work focuses on transformative treatments for neovascular age-related macular degeneration (nAMD), a leading cause of blindness. His most significant contribution is his pivotal role in the STAR trial, a rigorous, randomised, double-masked, sham-controlled device study published in 2024. This landmark investigation evaluated stereotactic radiotherapy as a novel approach to reduce the burden of frequent anti-VEGF injections for nAMD patients. By demonstrating that targeted ionising radiation can mitigate key pathogenic processes underlying the disease, Patel’s work offers a promising alternative to the current standard of care. With over 12 citations already, this trial has quickly become a cornerstone in the field, influencing clinical guidelines and sparking further research into combination therapies. Patel’s dedication to rigorous, patient-centred trial design has positioned him as a key figure in advancing non-pharmacological interventions for retinal disease, offering hope for reduced treatment frequency and improved quality of life for millions worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial
12 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 46

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago